Fig. 2.
Fig. 2. EFS after allogeneic BMT for patients with refractory anemia ± ringed sideroblasts (RA/RARS; n = 14) and all other diagnoses (n = 46).

EFS after allogeneic BMT for patients with refractory anemia ± ringed sideroblasts (RA/RARS; n = 14) and all other diagnoses (n = 46).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal